Milbrae, CA, United States of America

Dennis Chen


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dennis Chen - Innovator in Pharmaceutical Formulations

Introduction

Dennis Chen is a notable inventor based in Milbrae, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the stabilization of peptide compositions. His innovative work has led to the development of a unique lyophilized product that enhances the stability of therapeutic peptides.

Latest Patents

Dennis Chen holds a patent for a high temperature stable peptide formulation. This patent describes a stabilized pharmaceutical composition that can be reconstituted to generate an aqueous drug product. The formulation includes a peptide of sequence TDLQERGDNDISPFSGDGQPFKD, which is stabilized with a buffer, carbohydrate stabilizer, a nonionic bulking agent, and a surfactant. This combination has demonstrated exceptional stability when stored at elevated temperatures, making it a valuable advancement in pharmaceutical technology.

Career Highlights

Throughout his career, Dennis has focused on creating formulations that maintain the integrity of active ingredients under challenging conditions. His work at Acologix, Inc. has positioned him as a leader in the field of pharmaceutical innovation. His patent showcases his commitment to improving drug stability and efficacy.

Collaborations

Dennis Chen has collaborated with notable colleagues, including Russell Wayne Blacher and Byeong Chang. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Dennis Chen's contributions to the field of pharmaceutical formulations highlight his innovative spirit and dedication to improving drug stability. His work continues to influence the industry and pave the way for future advancements in therapeutic peptide applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…